Related Experiment Videos
Sample size formula for proportional hazards modelling of competing risks
Aurélien Latouche1, Raphaël Porcher, Sylvie Chevret
1Département de Biostatistique et Informatique Médicale, Hôpital Saint-Louis, Université Paris 7, Inserm Erm 321, Paris, France. aurelien.latouche@chu-stlouis.fr
Statistics in Medicine
|October 19, 2004
Summary
This study introduces new sample size formulas for analyzing competing risks in medical studies. These formulas help researchers accurately assess factors affecting failure causes in complex health outcomes.
Area of Science:
- Biostatistics
- Epidemiology
- Clinical Research Methodology
Background:
- Competing risks are common in medical studies, where multiple failure types can occur.
- Traditional cause-specific hazard models may not fully capture the impact of prognostic factors on specific failure types.
- Subdistribution hazard models offer an alternative approach for analyzing competing risks.
Purpose of the Study:
- To develop and validate approximate sample size formulas for proportional hazards modeling of subdistribution hazards.
- To account for both independent and correlated covariates in competing risk analyses.
- To provide practical tools for researchers designing studies with competing risks.
Main Methods:
- Derivation of approximate sample size formulas for subdistribution hazard models.
- Conducting numerical simulations to assess the accuracy and performance of the proposed formulas.
- Applying the formulas to real-world data from a randomized clinical trial and a prospective prognostic study.
Main Results:
- The proposed approximate sample size formulas provide valid estimates for planning competing risk studies.
- Numerical simulations confirm the reliability of the formulas under various scenarios.
- The formulas are applicable to studies with both independent and correlated covariates.
Conclusions:
- The developed sample size formulas are valuable tools for researchers in biostatistics and clinical epidemiology.
- Accurate sample size calculation is crucial for the efficient design and interpretation of studies involving competing risks.
- This work facilitates more robust analyses of therapeutic and prognostic factors in the presence of multiple failure types.